Munich, Germany & Petah Tikva, Israel, September 18, 2025 — Every day, patients undergo abdominal and chest CT scans for many reasons. Yet hidden in those images are often the earliest signs of chronic conditions that remain unnoticed until symptoms or complications appear. A missed diagnosis can mean fractures, heart attacks, or irreversible liver damage before treatment even begins.
Nanox AI and deepc are changing this reality. Through a new collaboration, Nanox’s AI clinically validated solution for liver health (HealthFLD), cardiac calcium scoring (HealthCCSng), and bone health analysis (HealthOST) are now available on the deepcOS® platform. Hospitals and imaging centers can use these tools to uncover the presence of liver steatosis disease, coronary artery disease, and findings associated with osteoporosis directly from scans already performed as part of routine care.
HealthFLD automatically measures, visualizes, and highlights liver density on standard CT images. Low liver density is a key marker for fatty liver disease. Running in the background while radiologists continue their usual reporting, the solution provides insights early enough for preventive care to begin before symptoms appear or complications escalate.
HealthOST identifies vertebral height loss and bone mineral density, which are key indicators of musculoskeletal disease. Osteoporosis is a common progressive bone disease among adults over 50 years of age that causes bones to weaken, leading to fractures. The software provides automated quantification of vertebral parameters from routine CT scans, delivering consistent and objective data to support physician evaluation, before life-altering fractures occur.
HealthCCSng has shown tangible results in several healthcare systems, identifying patientsat high risk of coronary artery disease while driving significant revenue to cardiology departments. It has also been seamlessly integrated with existing picture archiving and communication systems (PACS) and electronic medical records (EMR) systems, and enabled timely and appropriate preventive care.
Together, HealthFLD, HealthCCSng, and HealthOST help clinical environments, including hospitals, turn everyday imaging into a foundation for preventive care rather than late-stage intervention. By delivering findings directly into existing workflows, this collaboration gives clinicians timely information at the point of care, while hospitals gain secure and scalable AI deployment through deepcOS® with minimal IT effort and no disruption to existing systems. For patients, it offers a chance to address health risks earlier, when outcomes can be changed most.
Hospitals ready to make prevention a standard part of imaging can explore the Nanox AI solutions now available through deepcOS®: HealthFLD, HealthCCSng, and HealthOST.
About deepc
deepc enables the infrastructure layer that powers safe, vendor-neutral AI in medical imaging. Our platform, deepcOS®, spans the full product lifecycle: discovery, clinical validation, deployment, monitoring, and governance, so hospitals can adopt, scale, and continuously improve the AI tools that matter most to their workflows. Through rigorous, large-scale testing on independent and local data sets, deepc certifies every integrated algorithm for performance, robustness, and regulatory compliance. Clinicians can then easily activate best-in-class solutions across more than 80 indications, confident that patient safety and data privacy are protected by design. deepcOS® installs quickly and interfaces seamlessly with existing PACS/RIS, cloud, or on-prem environments. By abstracting complexity and preserving choice, deepc empowers radiology departments to build and evolve an AI-driven practice—faster, safer, and on their own terms today and into the future.
About Nanox.AI
Nanox AI Ltd. is the deep-learning medical imaging analytics subsidiary of Nanox Imaging Ltd. Nanox.AI solutions are developed to target highly prevalent chronic and acute diseases affecting large populations around the world. Leveraging AI, Nanox.AI helps clinicians extract valuable and actionable clinical insights from medical imaging that otherwise may go unnoticed, potentially initiating further medical assessment to establish individual preventative care pathways for patients. For more information, please visit www.nanox.vision/ai.
About Nanox
Nanox Imaging Ltd. (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by bringing a full solution of affordable medical imaging technologies based on advanced AI and a proprietary digital X-ray source. Nanox’s vision encompasses expanding the reach of Nanox technology both within and beyond hospital settings, providing a seamless end-to-end solution from scan to diagnosis, leveraging AI to enhance the efficiency of routine medical imaging technology and processes, in order to improve early detection and treatment and maintaining a clinically driven approach. The Nanox ecosystem includes Nanox.ARC – a multi-source digital tomosynthesis system that is cost-effective and user-friendly; an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic diseases, through Nanox’s subsidiary, Nanox AI Ltd; Nanox.CLOUD – a cloud-based software platform that manages and stores data collected by Nanox devices, and provides users with tools for in-depth imaging analysis; Nanox.MARKETPLACE – a proprietary decentralized marketplace through Nanox’s subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts, and a comprehensive teleradiology services platform. By improving early detection and treatment, Nanox aims to enhance better health outcomes worldwide. For more information, please visit www.nanox.vision.
